<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01389375</url>
  </required_header>
  <id_info>
    <org_study_id>GE IDE No. PCD00111</org_study_id>
    <nct_id>NCT01389375</nct_id>
  </id_info>
  <brief_title>Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial</brief_title>
  <acronym>ISAR-CLOSURE</acronym>
  <official_title>Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Are novel vascular closure devices noninferior to manual compression regarding access site
      complications after coronary angiography?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vascular closure devices have been shown to be safe and effective in reducing the time to
      hemostasis and immobilization when compared to manual compression following coronary
      angiography. This effect is beneficial in patients presenting with chronic back pain,
      prostate enlargement, mental impairment or other disorders that preclude prolonged bed rest.

      However, adequately powered large scale randomized trials with vascular closure devices
      remain a gap in the scientific literature.

      This trial compares, in a randomised design two novel vascular closure devices (FemoSeal &amp;
      ExoSeal) versus manual compression after coronary angiography. This study is aimed to
      investigate if novel vascular closure devices are noninferior to manual compression regarding
      access site complications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of arterial access related complications</measure>
    <time_frame>30 days</time_frame>
    <description>Composite of arterial access related complications, defined as the composite of:
Rate of ipsilateral groin hematomas with largest diameter exceeding 5 cm
Pseudoaneurysm
AV-Fistula
Major bleeding
Critical limb ischemia
Local infection
Surgical repair
Revascularisation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to hemostasis, from sheath removal to complete hemostasis</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device deployment failure</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for repeated manual compression after end of closure procedure</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-benefit Analysis</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">4524</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>FemoSeal®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: FemoSeal®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ExoSeal®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: ExoSeal®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual compression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Other: Manual compression</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FemoSeal®</intervention_name>
    <description>Closure device for femoral artery access closure</description>
    <arm_group_label>FemoSeal®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ExoSeal®</intervention_name>
    <description>Closure device for femoral artery access closure</description>
    <arm_group_label>ExoSeal®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual compression</intervention_name>
    <description>Conventional manual compression</description>
    <arm_group_label>Manual compression</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient between 18 and 85 years of age

          -  Patients undergoing femoral access coronary angiography

          -  Access only with 6 F sheath

          -  Patient must be competent for providing informed written consent

        Exclusion Criteria:

          -  Peripheral arterial occlusive disease

          -  Prior peripheral artery surgery

          -  Percutaneous coronary intervention

          -  Femoral access device closure in last 30 days

          -  Scheduled Coronary Angiography/Intervention within 90 days

          -  Critical limb ischemic

          -  Uncontrolled hypertension &gt;220/110 mmHg

          -  Coagulopathy (bleeding disorder)

          -  Local infection

          -  Common femoral artery lumen diameter &lt; 5 mm

          -  Allergy to absorbable suture

          -  Autoimmune Disease

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maryam Linhardt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Muenchen</name>
      <address>
        <city>Munich</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar</name>
      <address>
        <city>Munich</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Schulz-Schüpke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, Hoppe K, Böttiger C, Groha P, Bradaric C, Schmidt R, Bott-Flügel L, Ott I, Goedel J, Byrne RA, Schneider S, Burgdorf C, Morath T, Kufner S, Joner M, Cassese S, Hoppmann P, Hengstenberg C, Pache J, Fusaro M, Massberg S, Mehilli J, Schunkert H, Laugwitz KL, Kastrati A; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305.</citation>
    <PMID>25399273</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2011</study_first_submitted>
  <study_first_submitted_qc>July 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2011</study_first_posted>
  <last_update_submitted>June 8, 2016</last_update_submitted>
  <last_update_submitted_qc>June 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Closure Device</keyword>
  <keyword>Coronary Angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

